Menu
Search
|

Menu

Close
X

OraSure Technologies Inc OSUR.OQ (NASDAQ Stock Exchange Global Select Market)

17.82 USD
-0.04 (-0.22%)
As of 8:59 PM GMT
chart
Previous Close 17.86
Open 17.85
Volume 244,960
3m Avg Volume 300,831
Today’s High 18.14
Today’s Low 17.68
52 Week High 23.00
52 Week Low 10.79
Shares Outstanding (mil) 59.46
Market Capitalization (mil) 1,322.97
Forward P/E 41.42
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.83 Mean rating from 6 analysts

KEY STATS

Revenue (mm, USD)
FY17
167
FY16
128
FY15
120
EPS (USD)
FY17
0.511
FY16
0.348
FY15
0.144
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
41.42
32.90
Price to Sales (TTM)
vs sector
9.42
5.77
Price to Book (MRQ)
vs sector
5.75
5.41
Price to Cash Flow (TTM)
vs sector
35.65
23.42
Total Debt to Equity (MRQ)
vs sector
0.00
16.52
LT Debt to Equity (MRQ)
vs sector
0.00
12.22
Return on Investment (TTM)
vs sector
15.31
14.43
Return on Equity (TTM)
vs sector
15.72
16.13

EXECUTIVE LEADERSHIP

Stephen Tang
Independent Chairman of the Board, Since 2016
Salary: --
Bonus: --
Douglas Michels
President, Chief Executive Officer, Director, Since 2004
Salary: $612,339.00
Bonus: $646,586.00
Ronald Spair
Chief Financial Officer, Chief Operating Officer, Director, Since 2006
Salary: $480,069.00
Bonus: $362,074.00
Anthony Zezzo
Executive Vice President - Marketing and Sales, Since 2011
Salary: $391,572.00
Bonus: $188,998.00
Mark Kuna
Senior Vice President - Finance, Controller, Assistant Secretary, Since 2006
Salary: $261,783.00
Bonus: $127,060.00

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

150 WEBSTER ST
BETHLEHEM   PA   18015

Phone: +1503.6416115

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. It sells over-the-counter (OTC) cryosurgical products to consumers in North America, Europe, Central and South America, and Australia.

SPONSORED STORIES